Hacker News new | ask | show | jobs
by ZeroGravitas 632 days ago
In the article the drug maker suggestss that rather than negotiate the price down, US insurers stop buying the drug if he cuts the price too low.

That seems like a wild claim to make, but since it's just reported as if that was normal rather than a shocking scandal, I guess it's probably true.

1 comments

It's part of the grift. Expensive drugs means all sorts of middle men negotiate concessions to make themselves get better performance reviews.